ELISA Kit for Peptide YY (PYY)
PYY1; Peptide tyrosine tyrosine
- Product No.CEB067Hu
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- Sample Typeserum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
- Test MethodCompetitive Inhibition
- Assay Length2h
- Detection Range12.35-1,000pg/mL
- SensitivityThe minimum detectable dose of this kit is typically less than 4.77pg/mL.
- DownloadInstruction Manual
- UOM 48T96T 96T*5 96T*10 96T*100
For more details, please contact local distributors! US$ 665
For more details, please contact local distributors! US$ 2993
For more details, please contact local distributors! US$ 5653
For more details, please contact local distributors! US$ 46550
For more details, please contact local distributors!
This assay has high sensitivity and excellent specificity for detection of Peptide YY (PYY).
No significant cross-reactivity or interference between Peptide YY (PYY) and analogues was observed.
Matrices listed below were spiked with certain level of recombinant Peptide YY (PYY) and the recovery rates were calculated by comparing the measured value to the expected amount of Peptide YY (PYY) in samples.
|Matrix||Recovery range (%)||Average(%)|
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Peptide YY (PYY) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Peptide YY (PYY) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Peptide YY (PYY) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
|Pre-coated, ready to use 96-well strip plate||1||Plate sealer for 96 wells||4|
|Detection Reagent A||1||Assay Diluent A||1×12mL|
|Detection Reagent B||1×120µL||Assay Diluent B||1×12mL|
|Reagent Diluent||1×300µL||Stop Solution||1×6mL|
|TMB Substrate||1×9mL||Instruction manual||1|
|Wash Buffer (30 × concentrate)||1×20mL|
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
And then add 50µL prepared Detection Reagent A immediately.
Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.
|International Journal of Sport Studies||The Effects of Concurrent Resistance and Endurance Exercise on Hunger Feelings and PYY in Obese Men Com:Source|
|Annals of Applied Sport Science||Effect of an Acute Incremental Exercise on Plasma Peptide YY, Neuropeptide Y and IGF-1 Concentrations in Young Athletes Aassjournal:Source|
|Biomedical Reports||Calprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents. pubmed:28413639|
|Acta Diabetologica||Effect of lifestyle improvement program on the biomarkersof adiposity, inflammation and gut hormones in overweight/obese Asian Indians with prediabetes pubmed:28620678|
|Biomedical Reports||Calprotectin in serum and zonulin in serum and feces are elevated after introduction of a diet with lower carbohydrate content and higher fiber, fat and protein contents 10.3892/br.2017.865|
|Journal of Diabetes & Metabolism||High Fiber Fat and Protein Contents Lead to Increased Satiety Reduced Sweet Cravings and Decreased Gastrointestinal Symptoms Independently of Anthropometric Hormonal and Metabolic Factors 10.4172/2155-6156.1000733|
|Frontiers in Physiology||Ileal Transposition Surgery Decreases Fat Mass and Improves Glucose Metabolism in Diabetic GK Rats: Possible Involvement of FGF21 Pubmed:29593555|
|Food and Nutrition Research||Alignments of endocrine, anthropometric, and metabolic parameters in type 2 diabetes after intervention with an Okinawa-based Nordic diet Pubmed:29599686|
|Catalog No.||Related products for research use of Homo sapiens (Human) Organism species||Applications (RESEARCH USE ONLY!)|
|RPB067Hu01||Recombinant Peptide YY (PYY)||Positive Control; Immunogen; SDS-PAGE; WB.|
|SPB067Hu01||Synthetic Peptide YY (PYY)||Immunogen; Blocking Peptide.|
|CPB067Hu21||OVA Conjugated Peptide YY (PYY)||Immunogen; SDS-PAGE; WB.|
|PAB067Hu02||Polyclonal Antibody to Peptide YY (PYY)||WB; IHC; ICC; IP.|
|PAB067Hu01||Polyclonal Antibody to Peptide YY (PYY)||WB; IHC; ICC; IP.|
|MAB067Hu22||Monoclonal Antibody to Peptide YY (PYY)||WB; IHC; ICC; IP.|
|CEB067Hu||ELISA Kit for Peptide YY (PYY)||Enzyme-linked immunosorbent assay for Antigen Detection.|
|KSB067Hu11||ELISA Kit DIY Materials for Peptide YY (PYY)||Main materials for "Do It (ELISA Kit) Yourself".|